below ±17.8%, comparable to volume using Bland-Altman and also had high repeatability {CCC (0.84£CCC£0.99)}. Conclusion This study has highlighted the potential clinical utility of CTTA in the risk stratification of PNs. It has also shown that CTTA is a highly repeatable imaging biomarker of malignancy, akin to volume measurements but with the advantage of not requiring imaging follow-up. Introduction The circadian clock regulates murine immune responses by time of day, partly through the clock protein REVERBa, resulting in altered mortality after infection. The mechanisms regulating time of day differences are poorly understood in humans, where performing circadian studies presents a number of challenges. Lung transplantation, which is performed at any time of day to minimise organ ischaemic time, is an ideal model to study circadian effects on human immune responses. Methods Primary graft dysfunction (PGD) incidence after lung transplantation was examined for an eight year retrospective (2004)(2005)(2006)(2007)(2008)(2009)(2010)(2011)(2012) cohort (n=563) in one centre. Patients were excluded, a priori, if they had significant intra-operative complications, had a previous lung transplant, or if the donor lung had undergone ex-vivo perfusion. Circadian factors were also studied using PER2::Luc and REVERBa -/-mice and by pharmacological targeting of the circadian clock in primary alveolar macrophages from lung transplant recipients. Results The incidence of PGD grades 2/3 at 24 hours was temporarily elevated when organs were reperfused between 4 and 8 am (p<0.02) compared to other time points. Similar observations were made when the cohort was examined by operation start time (p<0.01). Sub-cohort analysis, defined using ISHLT relative contraindications, revealed that PGD incidence oscillated in a circadian manner (r
Introduction The circadian clock regulates murine immune responses by time of day, partly through the clock protein REVERBa, resulting in altered mortality after infection. The mechanisms regulating time of day differences are poorly understood in humans, where performing circadian studies presents a number of challenges. Lung transplantation, which is performed at any time of day to minimise organ ischaemic time, is an ideal model to study circadian effects on human immune responses. Methods Primary graft dysfunction (PGD) incidence after lung transplantation was examined for an eight year retrospective (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) cohort (n=563) in one centre. Patients were excluded, a priori, if they had significant intra-operative complications, had a previous lung transplant, or if the donor lung had undergone ex-vivo perfusion. Circadian factors were also studied using PER2::Luc and REVERBa -/-mice and by pharmacological targeting of the circadian clock in primary alveolar macrophages from lung transplant recipients. Results The incidence of PGD grades 2/3 at 24 hours was temporarily elevated when organs were reperfused between 4 and 8 am (p<0.02) compared to other time points. Similar observations were made when the cohort was examined by operation start time (p<0.01). Sub-cohort analysis, defined using ISHLT relative contraindications, revealed that PGD incidence oscillated in a circadian manner (r 2 =0.87, p=0.046). Investigations in PER2::Luc mice, which allows real time tracking of circadian oscillations, revealed that temperature and serum fluctuations, mimicking organ preservation, shifts the donor organ clock by 4-12 hours depending on time of retrieval. This could create circadian desynchrony between the transplanted organ and recipient. In macrophages, genomewide gene expression analysis of the role of REVERBa identified gene ontology terms linked to the regulation of lymphocyte function and activation, suggesting a functional link from the macrophage to the adaptive immune response. Furthermore, key PGD biomarkers are elevated (p<0.05) in macrophages from REVERBa -/-mice and are repressed (p<0.05) by REVERB ligands (GSK2945 and GSK2667) in macrophages from lung transplant recipients.
Conclusion This study suggests that the circadian clock could temporarily affect outcomes after lung transplantation due to recipient-donor circadian desynchrony. Ligands targeting the clock protein REVERBa repress key PGD biomarkers showing that this is a tractable therapeutic pathway. Rationale Timely, accurate diagnosis of invasive aspergillosis (IA) is key to enable initiation of antifungal therapy in lung transplantation. Despite promising novel fungal biomarkers, the lack of a diagnostic gold-standard creates difficulty in determining utility. Objectives This study aimed to use latent class modelling of fungal diagnostics to classify lung transplant recipients (LTR) with IA in a large single centre. Methods Regression models were used to compare composite biomarker testing of bronchoalveolar lavage to clinical and EORTC-MSG guideline-based diagnosis of IA with mortality used as a surrogate primary outcome measure. Bootstrap analysis identified radiological features associated with IA. Bayesian latent class modelling was used to define IA. Measurements and Main Results A clinical diagnosis of fungal infection (P =<0.001) and composite biomarker positive Results (P =<0.001) had significantly increased 12 month mortality. There was poor correlation between clinical diagnosis, EORTC-based IA diagnosis and composite biomarker positivity. Tracheobronchitis was positively predictive of a clinical and composite biomarker positive diagnosis of IA (p=0.004;95% CI-1.79-21.28 and p=0.03;95% CI-0.85-15.62 respectively). Latent class modelling resulted in the formation of 3 groups: Class 1: likely fungal infection; Class 2: unlikely fungal infection; Class 3: unclassifiable. A. fumigatus PCR was positive in~90% of class 1 LTRs compared to only 1% in class 2. Analysis of mortality showed a trend towards significance comparing class 1 with class 2 (p=0.06;HR-4.7;95% CI(0.91-24)) (figure 1).
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